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Abstract
Constraints arise naturally in many scientific experiments/studies such as in, epidemiology, biology, toxicology, etc. and
often researchers ignore such information when analyzing their data and use standard methods such as the analysis of
variance (ANOVA). Such methods may not only result in a loss of power and efficiency in costs of experimentation but also
may result poor interpretation of the data. In this paper we discuss constrained statistical inference in the context of linear
mixed effects models that arise naturally in many applications, such as in repeated measurements designs, familial studies
and others. We introduce a novel methodology that is broadly applicable for a variety of constraints on the parameters.
Since in many applications sample sizes are small and/or the data are not necessarily normally distributed and furthermore
error variances need not be homoscedastic (i.e. heterogeneity in the data) we use an empirical best linear unbiased
predictor (EBLUP) type residual based bootstrap methodology for deriving critical values of the proposed test. Our
simulation studies suggest that the proposed procedure maintains the desired nominal Type I error while competing well
with other tests in terms of power. We illustrate the proposed methodology by re-analyzing a clinical trial data on blood
mercury level. The methodology introduced in this paper can be easily extended to other settings such as nonlinear and
generalized regression models.
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Introduction
In many applications researchers are typically interested in
testing for trends or patterns in mean response among two or more
experimental or study groups rather than just testing if the groups
are different or not. For instance, toxicologists are typically
interested in detecting dose-related trends in mean response such
as trends in tumor incidence as the dose of a toxin increases [1–2].
In cell and circadian biology researchers are often interested in the
phase order of genes participating in cell cycle or the circadian
clock [3–10]. In all such situations researchers are interested in
testing for an order among statistical parameters. By performing
standard statistical procedures, e.g. the F-test in the case of
Euclidean space data, all a researcher can conclude is that there is
at least one group which is different from the rest of the
experimental groups (in the parameter of interest). Such a
conclusion is not very useful if the researcher is interested in
proving that the mean response is increasing with dose of the
toxin. Furthermore, as noted from the simulation study reported in
Figure 1, the power of the standard ANOVA based F-test can be
substantially smaller than the power of a test that is designed to
detect trend in mean response. For example, note that for a total
sample size of 48 (i.e. n = 12 per group), the standard ANOVA
based F-test yields of power of 0.58 whereas the Williams’
constrained test for trend (which will be described in detail later in
this article) yields a power 0.81. Conversely, as also noted in Figure
1, the sample size needed by Williams’ constrained test for a power
of approximately 0.80 is 48 whereas the F-test would require a
total sample size of 76. This simple motivating example illustrates
our point that, in addition to being scientifically relevant, a greater
efficiency can be achieved by using statistical methods that take
into consideration the investigator’s true hypothesis of interest
rather than performing a generic methodology, as often done in
scientific literature.
The field of statistics that deals with statistical methods designed
to test ordered or constrained hypotheses is commonly called order
restricted inference or constrained statistical inference. There
exists a very large body of literature on order restricted
(constrained inference) spanning nearly sixty years with four books
written on the subject, including a recent book by Silvapulle and
Sen [11]. Furthermore, for testing for some commonly encoun-
tered inequalities in the absence of any covariates in high
dimensional data (e.g. gene expression studies), a freely down-
loadable software called ORIOGEN (Order Restricted Inference
for Ordered Gene Expression) (http://www.niehs.nih.gov/
research/resources/software/biostatistics/oriogen/) was devel-
oped in [12,13].
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In many applications it is common for researchers to be
interested in comparing the population means of two or more
experimental conditions or groups after adjusting for covariates.
Depending upon the study design, as in repeated measurement
designs, it is common to use linear mixed effects models to account
for the underlying dependence structure as well as the covariates.
There exists several decades of literature on statistical inference in
linear mixed effects models and numerous books have been
written on the subject [14]. The standard statistical test for
comparing several population means in a linear mixed effects
model framework is the classical F-test which is widely used and is
available in most standard software packages such as SAS, R and
others. However, as noted earlier, by rejecting the null hypothesis
using the standard F-test one can only infer that at least one
population mean is different from the others and hence it may not
be ideal for ordered alternatives.
In the absence of any covariates, especially continuous
covariates, Mukerjee [15] noted that the usual tests for order
restrictions on the means of independent normal populations can
be extended to the case when normal populations are correlated as
in a repeated measurements design. Later Silvapulle [16]
generalized the methodology of [15] to some unbalanced designs
with incomplete data. He noted that within-subject correlations
make it difficult to generalize some tests into repeated measure-
ment models. Earlier, Singh and Wright [17] considered order-
restricted inference on fixed effects in a two-factor mixed model.
They presented an analogue to the usual F-test for homogeneity
and obtained several closed-form results.
It was not until [18–20] that statistical inference under
inequality constraints in linear mixed effects models was formally
addressed. In particular [18] developed an asymptotic likelihood
ratio test (LRT) for linear mixed effects model under homosce-
dastic errors. Since the asymptotic null distribution of LRT
depends upon nuisance parameters, they also provided suitable
bounds for the distribution using central chi-square distributions
with appropriate degrees of freedom. Although these bounds are
convenient, our simulation studies suggest that they could
potentially be too conservative, especially when the sample sizes
are small. Also, the basic assumption made in [18] is that the
random effects as well as random errors of the linear model are
homoscedastic and normally distributed. In practice this may not
necessarily be true. Motivated by the need for a methodology that
is robust to non-normality and heteroscedasticity, in Section 2 we
provide a general framework using the MINQUE ([14], [21,22])
and EBLUP type residual based bootstrap [23] to test for any
arbitrary linear inequality among means in a linear mixed effects
model with possibly heteroscedastic errors.
We present the methodology in Section 2. Results of our
simulation study are reported in Section 3. The proposed
methodology is illustrated in Section 4 using data from a clinical
trial comparing succimer treatment to placebo in children exposed
to mercury [24].
Statistical inference under constraints
2.1 The model and notations
Let
Y~X1h1zX2h2zUjze ð1Þ
Figure 1. Results of a simulation study to compare power and sample sizes of F-test in One-way ANOVA with the constrained
inference Williams’ type test where the critical values are derived using 10,000 bootstrap samples. The power of the Williams test was
estimated by averaging 1000 simulated where the critical values are estimated using 10,000 bootstrap samples. The power for F-test was determined
using PROC POWER in SAS (9.0). The null hypothesis was that the means of the four dose groups were equal (and zero) and the alternative hypothesis
was that the means of the four dose groups have an increasing trend with dose. Data representing the four dose groups were simulated from normal
populations with dose means taken to be 0, 0.1, 0.5 and 1, respectively. The actual values of the doses are irrelevant for the two methods described
here. The population standard deviation for the four populations was taken to be 1. Corresponding to the 14 different patterns of total sample sizes,
namely, 20, 24, 28, 32, 36, 40, 44, 48, 52, 60, 76, 80, 100, 116, the powers of the two methods are plotted. The Type I error was set to 0.05.
doi:10.1371/journal.pone.0084778.g001
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denote a linear mixed effects models where h1 is the vector of
treatment effects of the order p1|1, X1 is a design matrix of the
order N|p1 consisting of 0s and 1s, X2 is a known matrix of
covariates of the order N|p2 with corresponding (unknown)
regression parameter vector h2 of the order p2|1, and U is a
N|c matrix of known design constants. For convenience, we
denote X~ X1 : X2ð Þ and U~ U1 : U2 : ::: : Uq
 











where p~p1zp2. The observation vector Y is of the order N|1
and the unobservable random vectors j~ j01 : j
0





are independently distributed with mean 0 and covariance
matrices T and S, respectively, with
T~Cov j01 : j
0









i~1,2,:::,q, is a random vector of order ci|1: Motivated by
applications and for generality we assume a heteroscedastic error
structure for S, where S~diag s21In1 : s
2













Let A denote a r|p matrix of known constants, such that
g~Ah is an r|1 estimable linear function (i.e.C(A0)(C(X0),
where C denotes the column space of a matrix). The problem of
interest is to test hypotheses of the form:
H0 : g~0 versus HA : g§0, (2)
where the inequalities are component-wise, with at least one strict
inequality. For example, if one is interested in testing a simple
order HA : h11§h12§:::§h1p1 among the components of h1, then
A~ A1 : 0½  where 0 is the null matrix of suitable order and
A1~
1 {1 0 0 . . . 0











The matrix A can be suitably defined in the case of simple tree
order h11§h1i, i§2, or the umbrella order
h11§h12§h13:::§h1rƒh1rz1ƒh1rz2:::ƒh1p1 , for some r, etc.
2.2 The likelihood ratio test
Suppose j and e are independently and multivariate normally
distributed with log-likelihood function denoted by L(h,T,S). Let
(ĥ,T̂,Ŝ) denote the maximum likelihood estimators (MLE) of
(h,T,S) under no constraints and let (~h,~T,~S) denote the restricted
MLE (RMLE) under the alternative hypothesis (2). Then the
likelihood ratio test (LRT) statistic is given
bySlrt~2½L(~h,~T,~S){L(ĥ,T̂,Ŝ). Following the arguments in [18]
asymptotically, under the null hypothesis, we obtain the following






















k. Since in practice one does not know
the variance components, one may plug in the estimated values for
the unknown variance components in the above limiting
distribution [11]. Such plug-in estimators do not perform well
unless the sample size is very large. Furthermore, as the number of
treatment groups increases, the computation of the weights wi in
(3) is a challenging problem. Recognizing this challenge, simple
central chi-square distribution based bounds for the limiting
probability in (3) were derived in [18]. These probabilities can be
used for deriving bounds for the asymptotic p-values.
2.3 The residual bootstrap based test
There are three differences between our approach and the
above LRT approach. Firstly, rather than using the RMLE which,
at each step of the iteration, projects the unconstrained estimator
ĥonto the set of constraints in the alternative hypothesis, we use
the algorithm described in [25]. The estimation algorithm in [25]
is identical to the pool adjacent violators algorithm (PAVA) when
the constraint is a simple order, otherwise it is a modification of
PAVA. Our choice of PAVA is motivated by the fact that RMLE
can potential fail under some conditions [25]. Briefly, the PAVA is
implemented as follows. Consider a sequence of three numbers
X1, X2 and X3, and suppose in theory these numbers are expected
to be non-decreasing. However, suppose the observed values are 3,
1 and 4, respectively. The expected order is violated by the first
two numbers and therefore the PAVA averages the two violators,
resulting in the ordered numbers (3z1)=2,(3z1)=2 and 4.
Depending upon the situation, one could use weighted averages
rather than simple average. As noted in the flow chart provided in
Figure 2, our constrained estimation algorithm is flexible as one
can replace PAVA type estimator [25] by the orthogonal
projection estimator along the lines of [18]. Details of our
algorithm (Algorithm A.1) are provided in the Appendix S1.
Secondly, as noted above, because the asymptotic distribution of
the LRT is non-trivial to use in practice we use a computationally
simple non-parametric bootstrap to derive the p-values. Lastly, as
an alternative to LRT statistic we use a Williams’ type test statistic
[26–28]. Intuitively, the Williams’ test for monotonic order is a
generalization to the idea of standard t-test with the exception that
the numerator is the difference between the estimates of the largest
parameter and smallest parameter, where the estimates are
obtained by using the PAVA.








denote the PAVA type
constrained estimator derived according to the algorithm proposed
in this paper (Figure 2). Then as in [29] we may define Williams’
type test statistic [26–28] for various order restrictions. In the
following we provide the test statistic for three commonly
encountered order restrictions. In each case the null hypothesis
is H0 : h11~h12~:::~h1p
1
. For the others one may appeal to the
general framework provided in [26].
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Figure 2. Flow chart for constructing test statistic.
doi:10.1371/journal.pone.0084778.g002
Figure 3. Flow chart for deriving Bootstrap data under the null hypothesis.
doi:10.1371/journal.pone.0084778.g003
Constrained Inference in Biological Sciences
PLOS ONE | www.plosone.org 4 January 2014 | Volume 9 | Issue 1 | e84778








where Var(ĥ1i{ĥ11) is the estimated variance of the contrast
ĥ1i{ĥ11.















where Var(ĥ1j{ĥ1k) is the estimated variance of the contrast
ĥ1j{ĥ1k.
The bootstrap methodology to obtain the p-values is described
in the flow chart in Figure 3 and the details are provided in
Algorithm A.2 in the Appendix S1. Although in this paper we are
using the Williams’ type statistic W, one may use a likelihood ratio
type statistic (or any other constrained test statistic of user’s choice)
instead of W but use residual bootstrap described in this paper for
deriving the p-values. Such a strategy may result in a better power
for some patterns of the mean parameters. Thus the framework
developed in this paper is fairly flexible.
Simulation study
3.1 Study design
We evaluated the Type I error and power of the proposed
EBLUP bootstrap test for the case of simple order using the
proposed statistic (4). We compared our method with the
asymptotic likelihood ratio test [18] using the upper bound in
the equation (4.6) of [18] for deriving the critical values. We
considered a variety of patterns of parameters and covariance
matrices as follows:
Normally distributed data. The data were simulated using
model (1) with the number of subjects per each treatment
n:n1~n2~ . . . ~np1 , N~p1n, X1~Ip16Jn, a N|p1 design
matrix consisting of 0’s and 1’s, X2~Jp16u, where u was
generated as a n|1 vector, with its components uniformly
distributed in [0, 2], h2~2, a corresponding regression parameter,
U~Jp16In, j, a n|1 vector of independent subject random
effects, and Jk, a k|1 vector of 1s. The random vectors j,e were
independently and normally distributed with means 0 and
covariance matrices T and S, where T~Cov jð Þ~t2In. Simula-
tions were performed for p1 = 3, 5 treatment groups, n~10,50
subjects per each treatment and five different patterns of treatment
means h1: (P1) (0,0,..., 0), (P2) (0,..., 0, a), (P3) (0, a,..., a), (P4) (a,
2a,..., p1a), (P5) (0, a,..., a, 2a).
Here different values of a in the interval [0, 2] were chosen
arbitrarily to get a sense of power for a variety of patterns. Note
that pattern (P1) corresponds to the null pattern for computing
Type I error. Patterns (P2) to (P5) are patterns of h1 where the
components satisfy a simple order constraint h1ƒh2ƒ . . . ƒhp for
evaluating the power of the two test procedures. Two different
structures of S were considered, namely, homoscedastic error
structure with S~s2IN and heteroscedastic error structure with
S~diag s21In : s
2











are unknown variances with
Figure 4. Normal quantile-quantile plots of studentized residuals from regressing log organic mercury in the placebo and succimer
groups.
doi:10.1371/journal.pone.0084778.g004
Table 1. Type I errors for homoscedastic normally distributed
data.
p1 n t
2 Asymp-LRT Proposed method
3 10 1 0.03 0.05
3 50 1 0.01 0.03
3 10 0.2 0.05 0.04
3 10 2 0.04 0.05
3 50 2 0.01 0.03
5 10 1 0.02 0.03
5 10 0.2 0.02 0.04
5 10 2 0.02 0.04
doi:10.1371/journal.pone.0084778.t001
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N~p1n. The patterns of T and S considered in our simulations
are as follows:
N Homoscedastic case: We fixed s~1 and considered three patterns
of t2, namely t2~0:2,1,2.
N Heteroscedastic case: We fixed t2~1 and, as commonly done, we
chose the error variance to be a function of the mean, namely
s2~ s21,s
2




, where s2i ~h
2
i . In the case of null
hypothesis, i.e., hi~0Vi, we chose s2i ~0:1Vi:
Log-normally distributed data. All results are based on
500 simulation runs. We used 500 bootstrap runs to generate the
null distribution for the proposed bootstrap test. In all simulations
the nominal value for Type I error was taken to be 0.05.
3.2 Results
Complete simulation scenarios and results are presented in
Tables 1–6. Both tests operate at the desired nominal Type I error
rate, although sometimes the asymptotic likelihood ratio test tends
to be slightly conservative. Generally the proposed test is
substantially more powerful than the asymptotic likelihood ratio
test. In some cases the gains in power are as much as 0.36, e.g.
0.78 vs. 0.42 for heteroscedastic normally distributed data with
p1~5, n~10, h1~ 0,0,0,0,0:4ð Þ.
Illustration
We illustrate the proposed methodology using data from
patients in a randomized placebo-controlled, double-blind clinical
trial the Treatment of Lead-exposed Children trial, or TLC [30].
In TLC, 384 children aged 12–33 months were assigned to the
placebo group and 396 to the succimer group. In the succimer
group, up to three 26-day courses were administered. Cao et al.
Table 2. Power for homoscedastic normally distributed data.
p1 n h1 t
2 Asymp-LRT Proposed method
3 10 0 0.00 1.25 1 0.82 0.84
3 10 0 1.26 1.26 1 0.82 0.84
3 50 0 0.55 0.55 1 0.85 0.89
3 10 0 0.73 1.45 1 0.86 0.89
5 10 0 0.00 0.00 0.00 1.27 1 0.65 0.86
5 10 0 1.24 1.24 1.24 1.24 1 0.58 0.86
5 10 0 0.37 0.74 1.11 1.48 1 0.80 0.90
5 10 0 0.81 0.81 0.81 1.62 1 0.74 0.93
doi:10.1371/journal.pone.0084778.t002








3 10 0.1 0.10 2.37 1 0.04 0.03
3 10 0.1 0.20 0.20 1 0.03 0.04
3 10 0.1 0.09 0.36 1 0.03 0.03
3 50 0.1 0.10 0.01 1 0.01 0.03
3 50 0.1 0.02 0.02 1 0.02 0.04
5 10 0.1 0.10 0.10 0.10 0.16 1 0.01 0.04
5 10 0.1 0.20 0.20 0.20 0.20 1 0.01 0.04
5 10 0.1 0.11 0.44 0.99 1.76 1 0.01 0.04
5 10 0.1 0.11 0.11 0.11 0.45 1 0.02 0.05
doi:10.1371/journal.pone.0084778.t003
Table 4. Power for heteroscedastic normally distributed data.






3 10 0 0.00 1.54 1 0.82 0.88
3 10 0 0.45 0.45 1 0.81 0.82
3 10 0 0.30 0.60 1 0.82 0.80
3 50 0 0.00 0.10 1 0.70 0.74
3 50 0 0.15 0.15 1 0.86 0.92
3 50 0 0.08 0.16 1 0.95 0.93
5 10 0 0.00 0.00 0.00 0.40 1 0.42 0.78
5 10 0 0.45 0.45 0.45 0.45 1 0.68 0.81
5 10 0 0.33 0.66 1.00 1.33 1 0.96 0.88
5 10 0 0.34 0.34 0.34 0.67 1 0.71 0.82
doi:10.1371/journal.pone.0084778.t004







3 10 0.10 0.10 0.04 1 0.02 0.03
3 10 0.10 0.20 0.20 1 0.03 0.05
3 10 0.10 0.01 0.04 1 0.03 0.03
3 50 0.10 0.02 0.02 1 0.01 0.01
3 50 0.10 0.01 0.03 1 0.01 0.01
5 10 0.10 0.10 0.10 0.10 0.16 1 0.02 0.04
5 10 0.10 0.04 0.04 0.04 0.04 1 0.02 0.03
5 10 0.10 0.01 0.04 0.09 0.16 1 0.02 0.05
5 10 0.10 0.01 0.01 0.01 0.04 1 0.03 0.03
doi:10.1371/journal.pone.0084778.t005
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[24] measured and analyzed mercury levels in pre-treatment to
investigate whether succimer, a mercaptan compound known to
reduce blood lead concentration in children, also reduces blood
mercury concentration. At the baseline, blood mercury levels were
quantified in 657 samples (338 succimer and 319 placebo). At 1-
week post treatment, total mercury concentration was quantified
in 623 samples (313 succimer and 310 placebo). After 5 months of
treatment, blood mercury levels were quantified in 61 samples: 30
succimer treated children and 31 placebo treated children. To
investigate the efficacy of succimer treatment relative to placebo,
Cao et al. [24] tested for an increasing trend over time in the
difference between the mean mercury concentrations in the
succimer group and the placebo group, after adjusting for child’s
age, sex, race and the study center. The authors concluded that
there was no significant trend in the mean difference in mercury
concentrations in the succimer group and the placebo group.
Since their analysis ignored the covariance structure induced by
repeated measurements, we reanalyzed the data using the
proposed methodology which accounts for the repeated measure-
ments in the data. We fitted a linear mixed effects model with log
organic mercury as a dependent variable, treatment, race, gender,
center and age as fixed effects, and subject as a random effect. The
normal quantile-quantile plots (Figure 4) of resulting studentized
residuals in the placebo and succimer groups suggest that the data
are potentially non-normally distributed.
Denoting the difference in the mean log mercury levels at the tth
time between placebo and succimer groups as by ht (t = 1 for




with at least one strict inequality. The three UMLEs were 0.59,
0.92, 0.73 and the MINQUE-based constrained estimates were
0.59, 0.82, 0.82. Using the proposed test we obtained a bootstrap
p-value of 0.109. Thus, we are not able to reject the null
hypothesis in favor of a trend in the difference in means. These
results are consistent with conclusions of [24], that succimer
chelation for low level organic mercury exposure in children has
limited efficacy.
Summary and Concluding Remarks
Inequality constraints arise naturally in many applications, such
as toxicology, where researchers are interested in studying dose-
response of a chemical, or gene expression studies in oncology,
where a researcher may be interested in understanding the
changes in gene expression according to cancer stage. We
proposed a new method to test for inequality constraints. Since
the method uses Rao’s MINQUE theory (cf. [22]) for estimating
variance components and PAVA for estimating the means, it does
not necessarily require normality. In the simple order restriction,
our extensive simulation studies suggest that the proposed
methodology provides a better control of type I error than the
asymptotic likelihood ratio test of [18] when the data are non-
normally distributed. Our proposed methodology seems to control
the Type I error at the desired nominal level.
In the manuscript we considered one-dimensional order
constraints. In toxicology, researchers are often interested in
dose|time response surfaces, which results in a two-way
classification that can be expressed as a constrained inference
problem with constraints on rows and columns of a matrix. The
proposed testing procedure can be easily extended to deal with
such cases.
Supporting Information
Appendix S1 Description of Algorithms A.1 and A.2.
(DOCX)
Acknowledgments
Authors thank Grace Kissling and Bahjat Qaqish for their careful reading
of the manuscript and for their comments that helped improve the
presentation of the paper. Authors also thank Drs. Rogan and Cao for
providing us the data that were analyzed in this paper.
Author Contributions
Conceived and designed the experiments: SDP. Performed the experi-
ments: LF. Analyzed the data: LF. Wrote the paper: SDP LF AI.
References
1. Dinse GE (1985) Testing for a trend in tumor prevalence rates: I. Nonlethal
tumors. Biometrics, 41, 751–770.
2. Peddada SD, Dinse G, Kissling G (2007) Incorporating Historical Control Data
When Comparing Tumor Incidence Rates. J. Amer. Stat. Assoc., 102: 1212–
1220.
3. Lelandais G, Saint-Georges Y, Geneix C, Al-Shikhley L, Dujardin G, et al.
(2009) Spatio-Temporal Dynamics of Yeast Mitochondrial Biogenesis: Tran-
scriptional and Post-Transcriptional mRNA Oscillatory Modules. PLoS Comput
Biol 5(6): e1000409. doi:10.1371/journal.pcbi.1000409.
4. Jensen LJ, Jensen TS, de Lichtenberg U, Brunak S, Bork P (2006) Co-evolution
of transcriptional and posttranslational cell-cycle regulation. Nature. 443|5.
doi:10.1038/nature05186.
5. Rustici G, Mata J, Kivinen K, Lio P, Penkett CJ, et al. (2004) Periodic gene
expression program of the fission yeast cell cycle. Nature Genet., 36: 809–817.
6. Bahler J (2005) Cell-cycle control of gene expression in budding and fission yeast.
Annu. Rev. Genet., 39: 69–94.
7. Oliva A, Rosebrock A, Ferrezuelo F, Pyne S, Chen H, et al. (2005) The cell
cycle-regulated genes of Schizosaccharomyces pombe. PLoS Biol., 3(7): 1239–
1260.
Table 6. Power for log-normally distributed data.






3 10 0 0.00 1.54 1 0.90 0.98
3 10 0 0.45 0.45 1 0.81 0.85
3 10 0 0.30 0.60 1 0.85 0.90
3 50 0 0.00 0.20 1 0.92 0.88
3 50 0 0.15 0.15 1 0.57 0.68
3 50 0 0.08 0.16 1 0.89 0.69
5 10 0 0.00 0.00 0.00 0.40 1 0.44 0.77
5 10 0 0.45 0.45 0.45 0.45 1 0.66 0.83
5 10 0 0.10 0.20 0.30 0.40 1 0.79 0.75
5 10 0 0.34 0.34 0.34 0.67 1 0.72 0.94
5 50 0 0.00 0.00 0.00 0.20 1 0.97 0.96
5 50 0 0.20 0.20 0.20 0.20 1 0.66 0.92
5 50 0 0.08 0.08 0.08 0.16 1 0.87 0.74
doi:10.1371/journal.pone.0084778.t006
Constrained Inference in Biological Sciences
PLOS ONE | www.plosone.org 7 January 2014 | Volume 9 | Issue 1 | e84778
8. Fernandez M, Rueda C, Peddada SD (2012) Identification of a core set of
signature cell-cycle genes whose relative order of time to peak expression is
conserved across species. Nucleic Acids Research, 40: 2823–32. Epub 2011/12/
03. doi: 10.1093/nar/gkr1077.
9. Kondratova AA, Kondratov RV (2012) The circadian clock and pathology of
the ageing brain. Nature Reviews Neuroscience, doi:10.1038/nrn3208
10. Hastings MH, Reddy AB, Maywood ES (2003) A clockwork web: circadian
timing in brain and periphery, in health and disease. Nature Reviews
Neuroscience 4: 649–661.
11. Silvapulle MJ, Sen PK (2005) Constrained statistical inference: Inequality, order,
and shape restrictions. Hoboken, N.J.: Wiley-Interscience.
12. Peddada SD, Lobenhofer L, Li L, Afshari C, Weinberg C, et al. (2003) Gene
selection and clustering for time-course and dose-response microarray
experiments using order-restricted inference. Bioinformatics, 19: 834–841.
13. Peddada SD, Harris S, Zajd J, Harvey E (2005) ORIOGEN: Order Restricted
Inference for Ordered Gene Expression data. Bioinformatics, 21: 3933–3934.
14. Khuri AI, Mathew T, Sinha BK (1998) Statistical tests for mixed linear models.
New York: Wiley.
15. Mukerjee H (1988) Order restricted inference in a repeated measures model.
Biometrika 75: 616–617.
16. Silvapulle MJ (1997) On order restricted inference in some mixed linear models.
Statistics & Probability Letters 36: 23–27.
17. Singh B, Wright FT (1990) Testing for and against an order restriction in mixed-
effects models. Statistics & Probability Letters 9: 195–200.
18. Davidov O, Rosen S (2011) Constrained inference in mixed-effects models for
longitudinal data with application to hearing loss. Biostatistics 12: 327–340.
19. Rosen S, Davidov O (2012) Order-restricted inference for multivariate
longitudinal data with applications to the natural history of hearing loss.
Statistics in Medicine 31: 1761–1773.
20. Davis KA, Park CG, Sinha SK (2012) Testing for generalized linear mixed
models with cluster correlated data under linear inequality constraints. Canadian
Journal of Statistics 40: 243–258.
21. Rao CR (1972) Estimation of variance and covariance components in linear
models. Journal of the American Statistical Association 67: 112–115.
22. Rao CR, Kleffe J (1988) Estimation of variance components and applications.
Amsterdam; New York; New York, N.Y., U.S.A.: North-Holland.
23. Searle SR, Casella G, McCulloch CE (1992) Variance components. New York:
Wiley.
24. Cao Y, Chen A, Jones RL, Radcliffe J, Diethrich KN, et al. (2011) Efficacy of
succimer chelation of mercury at background exposures in toddlers: A
randomized trial. The Journal of Pediatrics 158: 480–485.
25. Hwang JTG, Peddada SD (1994) Confidence Interval Estimation Subject to
Order Restrictions. Annals of Statistics, 22: 67–93.
26. Williams DA (1971) A test for differences between treatment means when several
dose levels are compared with a zero dose control. Biometrics 27: 103–117.
27. Williams DA (1972) The comparison of several dose levels with a zero dose
control. Biometrics 28: 519–531.
28. Williams DA (1977) Some inference procedures for monotonically ordered
normal means. Biometrika 64: 9–14.
29. Peddada SD, Prescott KE, Conaway M (2001) Tests for order restrictions in
binary data. Biometrics 57: 1219–1227.
30. Rogan WJ (1998) The treatment of lead-exposed children (TLC) trial: Design
and recruitment for a study of the effect of oral chelation on growth and
development in toddlers. Paediatric and Perinatal Epidemiology 12: 313–333.
Constrained Inference in Biological Sciences
PLOS ONE | www.plosone.org 8 January 2014 | Volume 9 | Issue 1 | e84778
